{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:44:49Z","timestamp":1761965089702,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12876-019-0982-4","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T10:03:36Z","timestamp":1556186616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7300-3665","authenticated-orcid":false,"given":"Haruka","family":"Toyonaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Shimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Inokuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"982_CR1","first-page":"1741","volume":"18","author":"MH Ellman","year":"1991","unstructured":"Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991;18:1741\u20133.","journal-title":"J Rheumatol"},{"key":"982_CR2","first-page":"462","volume-title":"World Health Organization classification of Tumours of Haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. World Health Organization classification of Tumours of Haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: IARC Press; 2017. p. 462\u20134."},{"key":"982_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/cas.13249","volume":"108","author":"Y Gion","year":"2017","unstructured":"Gion Y, Iwaki N, Takata K, Takeuchi M, Nishida K, Orita Y, et al. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci. 2017;108:1271\u201380.","journal-title":"Cancer Sci"},{"key":"982_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00296-017-3764-8","volume":"37","author":"S Takanashi","year":"2017","unstructured":"Takanashi S, Aisa Y, Ito C, Arakaki H, Osada Y, Amano Y, et al. Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression. Rheumatol Int. 2017;37:1629\u201333.","journal-title":"Rheumatol Int"},{"key":"982_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ijc.24287","volume":"125","author":"LA Anderson","year":"2009","unstructured":"Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009;125:398.","journal-title":"Int J Cancer"},{"key":"982_CR6","first-page":"322","volume":"34","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda JI, Tomita Y, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34:322\u201331.","journal-title":"J Rheumatol"},{"key":"982_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ejh.12116","volume":"91","author":"A Ichikawa","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein\u2013Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013;91:20\u20138.","journal-title":"Eur J Haematol"},{"key":"982_CR8","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/art.20311","volume":"50","author":"F Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum. 2004;50:1740\u201351.","journal-title":"Arthritis Rheum"},{"key":"982_CR9","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/acr.22306","volume":"66","author":"T Kameda","year":"2014","unstructured":"Kameda T, Dobashi H, Miyatake N, Inoo M, Onishi I, Kurata N, et al. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients. Arthritis Care Res. 2014;66:1302\u20139.","journal-title":"Arthritis Care Res"},{"key":"982_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1523-1747.2003.12040.x","volume":"120","author":"CF Paul","year":"2003","unstructured":"Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol. 2003;120:211\u20136.","journal-title":"J Invest Dermatol"},{"key":"982_CR11","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/modpathol.2009.131","volume":"22","author":"RP Hasserjian","year":"2009","unstructured":"Hasserjian RP, Chen S, Perkins SL, De Leval L, Kinney MC, Barry TS, et al. Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol. 2009;22:1532\u201340.","journal-title":"Mod Pathol"},{"key":"982_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1044579X0200086X","volume":"12","author":"N Raab-Traub","year":"2002","unstructured":"Raab-Traub N. Epstein\u2013Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002;12:431\u201341.","journal-title":"Semin Cancer Biol"},{"key":"982_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.coviro.2012.07.001","volume":"2","author":"N Raab-Traub","year":"2012","unstructured":"Raab-Traub N. Novel mechanisms of oncogenesis by the Epstein\u2013Barr virus. Curr Opin Virol. 2012;2:453\u20138.","journal-title":"Curr Opin Virol"},{"key":"982_CR14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/j.1349-7006.2010.01517.x","volume":"101","author":"N Niitsu","year":"2010","unstructured":"Niitsu N, Okamoto M, Nakamine H, Hirano M. Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate. Cancer Sci. 2010;101:1309\u201313.","journal-title":"Cancer Sci"},{"key":"982_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-008-9069-8","volume":"26","author":"R Rizzi","year":"2009","unstructured":"Rizzi R, Curci P, Delia M, Rinaldi E, Chiefa A, Specchia G, et al. Spontaneous remission of \u201cmethotrexate-associated lymphoproliferative disorders\u201d after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol. 2009;26:1\u20139.","journal-title":"Med Oncol"},{"key":"982_CR16","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/rheumatology\/kex002","volume":"56","author":"S Saito","year":"2017","unstructured":"Saito S, Kaneko Y, Yamaoka K, Tokuhira M, Takeuchi T. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Rheumatol. 2017;56:940\u20136.","journal-title":"Rheumatol."},{"key":"982_CR17","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3109\/10428194.2015.1022769","volume":"56","author":"Y Inui","year":"2015","unstructured":"Inui Y, Matsukoka H, Yakushijin K, Okamura A, Shimada T, Yano S, et al. Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leuk Lymphoma. 2015;56:3045\u201351.","journal-title":"Leuk Lymphoma"},{"key":"982_CR18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood.V99.3.815","volume":"99","author":"M Yamaguchi","year":"2002","unstructured":"Yamaguchi M, Seto M, Okamoto M, Ichinohasama R, Nakamura N, Yoshino T, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815\u201321.","journal-title":"Blood."},{"key":"982_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12328-015-0624-5","volume":"9","author":"K Ikeda","year":"2016","unstructured":"Ikeda K, Nakamura T, Kinoshita T, Fujiwara M, Uose S, Someda H, et al. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation. Clin J Gastroenterol. 2016;9:17\u201321.","journal-title":"Clin J Gastroenterol"},{"key":"982_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/MAJ.0b013e3181acbb49","volume":"338","author":"K Satoh","year":"2009","unstructured":"Satoh K, Yoshida N, Imaizumi K, Komatsuda A. Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis. Am J Med Sci. 2009;338:334\u20135.","journal-title":"Am J Med Sci"},{"key":"982_CR21","doi-asserted-by":"publisher","first-page":"12993","DOI":"10.3748\/wjg.v20.i36.12993","volume":"20","author":"C Vetro","year":"2014","unstructured":"Vetro C, Romano A, Amico I, Conticello C, Motta G, Figuera A, et al. Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up. World J Gastroenterol. 2014;20:12993\u20133005.","journal-title":"World J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-019-0982-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T23:04:11Z","timestamp":1587683051000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-019-0982-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1186\/s12876-019-0982-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"type":"electronic","value":"1471-230X"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"18 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written consent was obtained from the patient. As this is a case report, approval from the institutional review board was not needed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"62"}}